Books in Infectious diseases and chemotherapy

21-30 of 61 results in All results

Coronaviruses

• 1st Edition
• Volume 96
• September 30, 2016
• John Ziebuhr
• English
• Hardback 978-0-12-804736-1

  9 7 8 - 0 - 1 2 - 8 0 4 7 3 6 - 1
• eBook 978-0-12-805115-3

  9 7 8 - 0 - 1 2 - 8 0 5 1 1 5 - 3

Coronaviruses, the latest volume in the Advances in Virus Research series first published in 1953, covers a diverse range of in-depth reviews, providing a valuable overview of the field. This series is a valuable resource for virologists, microbiologists, immunologists, molecular biologists, pathologists, and plant researchers.

Advances in Virus Research

• 1st Edition
• Volume 95
• April 22, 2016
• Margaret Kielian + 2 more
• English
• Hardback 978-0-12-804820-7

  9 7 8 - 0 - 1 2 - 8 0 4 8 2 0 - 7
• eBook 978-0-12-805236-5

  9 7 8 - 0 - 1 2 - 8 0 5 2 3 6 - 5

First published in 1953, the Advances in Virus Research series covers a diverse range of in-depth reviews, providing a valuable overview of the current field of virology.

Advances in Virus Research

• 1st Edition
• Volume 94
• March 10, 2016
• Margaret Kielian + 2 more
• English
• Hardback 978-0-12-804821-4

  9 7 8 - 0 - 1 2 - 8 0 4 8 2 1 - 4
• eBook 978-0-12-805237-2

  9 7 8 - 0 - 1 2 - 8 0 5 2 3 7 - 2

Published since 1953, Advances in Virus Research covers a diverse range of in-depth reviews, providing a valuable overview of the current field of virology.

Vascular Responses to Pathogens

• 1st Edition
• October 27, 2015
• Felicity N.E. Gavins + 1 more
• English
• Hardback 978-0-12-801078-5

  9 7 8 - 0 - 1 2 - 8 0 1 0 7 8 - 5
• eBook 978-0-12-801325-0

  9 7 8 - 0 - 1 2 - 8 0 1 3 2 5 - 0

Vascular Responses to Pathogens focuses on the growing research from leaders in the field for both the short and long-term impact of pathogens on the vasculature. It discusses various organisms, including bacteria, parasites, and viruses, and their role in key events leading to vascular disease. Formatted to discuss the topic of the interaction of pathogens with the vascular rather than individual diseases described separately, this reference demonstrates that common mechanisms are at play in many different diseases because they have a similar context, their vasculature. This all-inclusive reference book is a must-have tool for researchers and practicing clinicians in the areas of vascular biology, microvasculature, cardiology, and infectious disease.

Advances in Virus Research

• 1st Edition
• Volume 93
• June 23, 2015
• Karl Maramorosch + 2 more
• English
• Hardback 978-0-12-802179-8

  9 7 8 - 0 - 1 2 - 8 0 2 1 7 9 - 8
• eBook 978-0-12-802424-9

  9 7 8 - 0 - 1 2 - 8 0 2 4 2 4 - 9

Published since 1953, Advances in Virus Research covers a diverse range of in-depth reviews, providing a valuable overview of the current field of virology.

Nanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases

• 1st Edition
• May 23, 2015
• Mahendra Rai + 1 more
• English
• Paperback 978-0-12-801317-5

  9 7 8 - 0 - 1 2 - 8 0 1 3 1 7 - 5
• eBook 978-0-12-801471-4

  9 7 8 - 0 - 1 2 - 8 0 1 4 7 1 - 4

Nanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases delivers comprehensive coverage of the application of nanotechnology to pressing problems in infectious disease. This text equips readers with cutting-edge knowledge of promising developments and future prospects in nanotechnology, paying special attention to microbes that are now resistant to conventional antibiotics, a concerning problem in modern medicine. Readers will find a thorough discussion of this new approach to infectious disease treatment, including the reasons nanotechnology presents a promising avenue for the diagnosis, treatment, and prophylaxis of infectious diseases.

Primary Immunodeficiency Disorders

• 1st Edition
• August 26, 2014
• Amos Etzioni + 1 more
• English
• Hardback 978-0-12-407179-7

  9 7 8 - 0 - 1 2 - 4 0 7 1 7 9 - 7
• eBook 978-0-12-411554-5

  9 7 8 - 0 - 1 2 - 4 1 1 5 5 4 - 5

Primary Immunodeficiency Disorders: A Historic and Scientific Perspective provides a complete historical context that is crucial for students and researchers concerned with primary immunodeficiency. When researchers have a poor understanding of the way we arrived where we are in research, they can miss important points about a disease, or miss out on how to approach new diseases. This historical knowledge of research can assist greatly by showing how it was done in the past, demonstrating the successes and failures, so that it can be done better in the future. This book provides an understanding of the process going from clinical problem to lab and back to the clinic, based on historical experiences. Its chapters proceed from the discovery of the T and B cell lineages through the first BMT for immunodeficiency disorder; lab investigation and gene therapy for PID; the discovery of the gene for AT and its function; understanding cytokine defects; and many other stops along the way.

Imported Infectious Diseases

• 1st Edition
• August 18, 2014
• Fernando Cobo
• English
• Hardback 978-1-907568-57-2

  9 7 8 - 1 - 9 0 7 5 6 8 - 5 7 - 2
• eBook 978-1-908818-73-7

  9 7 8 - 1 - 9 0 8 8 1 8 - 7 3 - 7

The increase of immigrant population in developed countries (mainly in Europe and North America) together with an important increase of international travel worldwide are the two most important causes that have contributed to the introduction and diagnosis of imported/tropical infectious diseases in these countries. These factors have had an important impact in developed countries in both social and economic aspects. Imported Infectious Diseases focuses not only on describing the infections, but also in evaluating the current epidemiology, the economic and social impact and the possibility to apply immunization measures and vaccines. The main purpose of this book is to give an overview of the current most important and frequent imported infectious diseases in developed countries. The first chapter informs about the medical services that are being offered to the immigrants in the main developed countries depending on the legal situation. Following chapters describe the main surveillance systems for these kinds of diseases, mainly in Europe and North America. Finally, remaining chapters contain sections on epidemiology, pathogenesis, clinical features, diagnosis, treatment and prevention.

Neurovirology

• 1st Edition
• Volume 123
• July 8, 2014
• Alex C. Tselis + 1 more
• English
• eBook 978-0-7020-4539-4

  9 7 8 - 0 - 7 0 2 0 - 4 5 3 9 - 4

This volume in the Handbook of Clinical Neurology series provides a complete review of the history, science and current state of neurovirology. It covers the science and clinical presentation, diagnosis, and treatment of viruses of the brain and central nervous system, and is a trusted resource for scholars, scientists, neuroscientists, neurologists, virologists, and pharmacologists working on neurovirology. Neurovirology has been significantly bolstered by modern technologies such as PCR and MRI with direct impact on isolating viruses and advancing therapeutics based on molecular medicine. These advances are particularly important today with the introduction of emerging and re-emerging diseases such as HIV/AIDS, Nipah encephalitis and the appearance of West Nile encephalitis in the western hemisphere.

Rare Diseases and Orphan Drugs

• 1st Edition
• May 26, 2014
• Jules J. Berman
• English
• Hardback 978-0-12-419988-0

  9 7 8 - 0 - 1 2 - 4 1 9 9 8 8 - 0

Rare Diseases and Orphan Drugs shows that much of what we now know about common diseases has been achieved by studying rare diseases. It proposes that future advances in the prevention, diagnosis, and treatment of common diseases will come as a consequence of our accelerating progress in the field of rare diseases. Understanding the complex steps in the development of common diseases, such as cancer, cardiovascular disease, and metabolic diseases, has proven a difficult problem. Rare diseases, however, are often caused by aberrations of a single gene. In rare diseases, we may study how specific genetic defects can trigger a series of events that lead to the expression of a particular disease. Often, the disease process manifested in a certain rare disease is strikingly similar to the disease process observed in a common disease. This work ties the lessons learned about rare diseases to our understanding of common ones. Chapters covering the number of common diseases are minimized, while rare diseases are introduced as single diseases or as members of diseases classes. After reading this book, readers will appreciate how further research into the rare diseases may lead to new methods for preventing, diagnosing, and treating all diseases, rare or common.